3
RUDN University Scientists in Pharmaceutical Technology Proved Effectiveness of New Dosage Form

RUDN University Scientists in Pharmaceutical Technology Proved Effectiveness of New Dosage Form

RUDN University scientists together with colleagues from Switzerland proved in a clinical trial the effectiveness of a new dosage form — amorphous solid dispersion. This is the first such study in humans to show the mechanism of action of this form of drug release. In the future, it will help to increase the effectiveness of drugs and use new active substances for treatment.

One of the main reasons for the dropout of new oral drugs at the preclinical and clinical stages of development is low bioavailability. The drug itself can be effective, but it is poorly absorbed in the body because of its low solubility. Amorphous solid dispersion (ASD) is a new form of drug release that has the potential to solve this problem. ASD consists of a drug substance and a polymer framework that “binds” the drug and improves its solubility, thus increasing bioavailability. RUDN University scientists in the field of pharmaceutical technology, together with colleagues from Switzerland, conducted a clinical study and proved the effectiveness of ASD. This is the first such human trial.

“Despite the research effort on mechanisms of increased bioavailability through ASDs during the last decades, these mechanisms are far from being understood in every detail. Furthermore, the translation from preclinical studies to clinical outcomes in humans has not been validated. This clinical study aimed to investigate the mechanisms and effects of a particle forming ASD on bioavailability in humans to understand the complex absorption from ASDs in humans. To our best knowledge, there are currently neither documented data nor methods providing such insights”, Rimma Abramovich, Doctor of Pharmaceutical, Director of the Shared Research and Education Center of the RUDN University

The clinical study involved 16 volunteers; healthy men aged 20 to 38 years. As a model medicine, doctors used the antiviral drug efavirenz, which is used in the treatment of HIV infection. Participants in the study took efavirenz orally in three different forms in three interventions — 50 mg in the form of solid ASD, 50 mg in the form of dissolved ASD, and 3 mg of a molecular solution of efavirenz. To avoid distortion of the results, doctors maintain a washout period of 14 to 21 days. After each intervention, the doctors took a blood test and measured the pharmacokinetic profile — the dynamics of efavirenz concentration in blood plasma over time.

It turned out that ASD in solid form works in the same way as a regular efavirenz tablet — the maximum concentration of about 6.5 nanograms per milliliter is reached in two hours. And the dissolved ASD acts as a molecular solution of the drug — the concentration of the drug in the blood reached approximately the same value after the same time — about 10 nanograms per milliliter after 50-60 minutes. However, given that the molecular solution is absorbed from the intestine into the blood passively (that is, without additional chemical reactions), the scientists calculated that the actual concentration of the drug in the intestine in the case of dissolved ASD is 16.7 times higher than in the case of conventional efavirenz. This means that the dissolved ASD behaves like a so-called supersaturated solution; meaning that it contains 10 times more dissolved matter than it can dissolve under normal conditions.

“We could show that drug absorption from drug-rich particles, formed upon the dissolution of the ASD, was fast and complete in humans”, Rimma Abramovich, Doctor of Pharmaceutical, Director of the Shared Research and Education Center of the RUDN University.

30 Jan 2018
The conference on international arbitration, where law students from European universities simulate court proceedings and alternately defend the interests of the respondent and the orator.
957
Student's Scientific Initiatives View all
03 Nov 2017
June 22 - 26, 2017 in Barnaul, Altai State University, took place the Summer Academy of the BRICS Youth Assembly, an international event that brought together representatives of different countries
1281
Similar newsletter View all
26 Dec 2022
Tissue architecture, cell organization, biomedical products: RUDN University opens a new research and educational resource center

On October 4, the Research and Educational Resource Center (REC) of innovative technologies of immunophenotyping, digital spatial profiling and ultrastructural analysis (molecular morphology) opened at the RUDN.

34
26 Dec 2022
RUDN scientists suggested how to help the soils of Zaryadye Park

RUDN University scientists conducted a comprehensive soil and environmental survey and took more than 80 soil samples in Zaryadye Park. An assessment of the physicochemical, microbiological, and ecotoxicological properties of soils made it possible to develop recommendations and a plan for the care of soils in analogous landscapes in the park.

50
26 Dec 2022
RUDN University Chemist Creates Nanofilter to Clean Water from Toxic Dyes

RUDN University chemist with colleagues from India and Korea created a nanofilter for water purification from synthetic dyes. The graphene-based composite can quickly remove up to 100% of harmful compounds from water, and it can be used up to seven times without losing efficiency. In addition, the synthesis of the nanofilter itself is economical and environmentally friendly.

36
Similar newsletter View all